GENE
$2.29
Genetic Tech Spn Ads
$.25
12.25%
GENE
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Thursday
Sep 14
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when GENE reports earnings?
Beat
Meet
Miss

Where is GENE's stock price going from here?
Up
Flat
Down
Stock chart of GENE
Analysts
Summary of analysts' recommendations for GENE
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Genetic Technologies was the first company in the world to recognize important new applications for non-coding DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Peers
BiogenGilead SciencesBluebird BioAmgenNeurocrine BiosciencesSeattle GeneticsQiagen N.V.RepligenBioCryst PharmaceuticalsNovavax